Skip to main content

Embedding environmental sustainability into pharma’s DNA

As the climate crisis escalates, so too does scrutiny of how companies are addressing the problems.

The pharmaceutical (pharma) industry’s involvement in environmental issues is multifaceted, with implications for the entire product value chain. From research and development (R&D) and supply chain (procurement, manufacturing, transportation, logistics and other services), to patient engagement, modes of delivery and the disposal of products, all aspects of the process are affected.

Although there are complex challenges to overcome, there are also many opportunities to accelerate the pace of change and unlock new business prospects. To achieve their sustainability ambitions, pharma companies need to undergo a fundamental transformation spearheaded by strong leadership, enhanced collaboration and a willingness to innovate with evidence-based improvement initiatives embedded across the industry.

Did you find this useful?

Thanks for your feedback

If you would like to help improve further, please complete a 3-minute survey